Research News
New York City Researches Preliminary Outcomes of COVID-19 for Gynecologic Cancer Patients
(August 6, 2020) Using medical records for 121 patients with gynecologic cancer and COVID-19, researchers were able to conduct an early look at the implications of a COVID-19 diagnosis on a patient with a gynecological cancer diagnosis…
OCRA-Funded Study Finds Menopausal Hormone Therapy Associated with Improved Survival from Ovarian Cancer
(July 27, 2020) Research from the Ovarian Cancer Association Consortium (OCAC) found that “using menopausal hormone therapy prior to diagnosis extends ovarian cancer survival…
The Overview: July 2020
There’s so much happening at OCRA – from groundbreaking research to advocacy work, patient support to fundraising efforts. Starting this summer, we will share periodic highlights so that you can stay up to date on the latest…
Taking Statins Linked to Lower Mortality in Ovarian Cancer Patients
(July 7, 2020) Presented as part of the American Association for Cancer Research (AACR) Virtual Annual Meeting, Dr…
Finding Sparks, Fueling Motivation | Meet a Scientist
Hui Shen, PhD, spoke of a particular moment that helped cement her commitment to ovarian cancer research. She was working on a complicated project that required a new genomics technology to work…
Healthy Lifestyle Linked to Better Prognosis
(June 24, 2020) Published this month in the International Journal of Cancer, researchers in Australia have found that “A healthy lifestyle after diagnosis, in particular not smoking and being physically active, may help women with ovarian cancer…
OCRA Now Accepting Applications for 2021 Research Grants
(June 11, 2020) Letters of Intent (LOIs) for Ovarian Cancer Research Alliance’s 2021 scientific grant awards are now open for submission. LOIs are due by July 10, 2020. Accepting LOIs is step one of OCRA’s highly competitive grant process…
Convenient Spit Test Helps Women Assess Cancer Risk From the Comfort of Their Own Home
First-of-its-kind clinical trial validates remote genetic counseling (New York) June 01, 2020 – Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who…
When a Virus is a Good Thing | Meet a Scientist
Scared. Overwhelmed. Exhausted. Befuddled. These are common words one might use to describe how we feel during this unprecedented time in history…
Niraparib Receives FDA Approval as First-Line Maintenance Therapy for Advanced Ovarian Cancer
(May 4, 2020) On April 29th, the Food and Drug Administration approved niraparib (Zejula, GlaxoSmithKline) as a first-line maintenance treatment for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer, regardless of BRCA…
SGO 2020 Highlights
(April 17, 2020) The Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer brings together women’s healthcare professionals from across the globe to discuss the latest findings in gynecologic oncology…
COVID-19 and Oncology Clinical Trials: An Update
(April 15) The novel coronavirus, COVID-19, has become nearly all consuming. It’s impossible to turn on the news, browse social media, or walk outside without being reminded of the new, albeit temporary, state of the world…